Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The genetics of multiple sclerosis: an up-to-date review.
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Genetic and epigenetic fine mapping of causal autoimmune disease variants.
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
About Tysabri
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
Aging, widowhood, multiple sclerosis, and a dog.
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Harnessing monocyte-derived macrophages to control central nervous system pathologies: No longer 'if' but 'how'
Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
NMO spectrum presenting as partial myelitis.
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
The role of Acinetobacter in the pathogenesis of multiple sclerosis examined by using Popper sequences.
Type 1 immune response in progressive multiple sclerosis.
What to expect after natalizumab cessation in a real-life setting.
Sexual Behavior, Body Image, and Partnership in Chronic Illness: A Comparison of Huntington's Disease and Multiple Sclerosis.
Natalizumab to fingolimod washout in patients at risk of PML: When good intentions yield bad outcomes.
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study.
Pages
« first
‹ previous
…
161
162
163
164
165
166
167
168
169
…
next ›
last »